STOCK TITAN

Twist Bioscience Corporation (TWST) Stock News, Apr-Jul 2023

TWST NASDAQ

Twist Bioscience Corporation reports developments in synthetic biology built around its silicon-based DNA synthesis platform. Company updates cover synthetic DNA tools and services for diagnostics, therapeutics, industrial, agriculture and research markets, including oligos, genes, proteins, libraries, characterization data, antibody discovery solutions and NGS workflow tools.

Recurring announcements include fiscal results, business updates, product launches such as expanded clonal gene capabilities and library preparation kits, antibody discovery licensing, investor presentations and Nasdaq inducement equity awards for new employees.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
management
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.58%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.29%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
Rhea-AI Summary

Twist Bioscience Corporation (NASDAQ: TWST) has launched the AsterExome panel, a tool designed to enhance oncology research through comprehensive whole exome sequencing (WES). This panel covers 620 cancer-associated genes, integrated into the AVATAR sequencing program by Aster Insights. It aims to improve the efficiency and accuracy of cancer research, identifying copy number variations and somatic mutations that standard panels may overlook. The collaboration with Aster Insights brings together extensive clinicogenomic data, accelerating the discovery of personalized therapies. This innovation leverages Twist’s proprietary DNA synthesis technology, positioning the company favorably in the competitive oncology research landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
none

FAQ

What is the current stock price of Twist Bioscience (TWST)?

Twist Bioscience (TWST) last closed at $103.32.

What is the market cap of Twist Bioscience (TWST)?

The market cap of Twist Bioscience (TWST) is approximately $7.0B.